These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2164207)

  • 21. Monoclonal antibodies to human squamous cell carcinoma of the lung and their application to tumor diagnosis.
    Kyoizumi S; Akiyama M; Kouno N; Kobuke K; Hakoda M; Jones SL; Yamakido M
    Cancer Res; 1985 Jul; 45(7):3274-81. PubMed ID: 4005855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Carbohydrate antigens in pleural effusion from patients with lung cancer].
    Hiratani K; Sakito O; Mukae H; Morikawa N; Kadota J; Fukushima K; Komori K; Hirota M; Hara K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Jun; 27(6):673-8. PubMed ID: 2552211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma.
    Kohno N; Akiyama M; Kyoizumi S; Hakoda M; Kobuke K; Yamakido M
    Jpn J Clin Oncol; 1988 Sep; 18(3):203-16. PubMed ID: 3411786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The diagnostic utility of D2-40 for malignant mesothelioma versus pulmonary carcinoma with pleural involvement.
    Saad RS; Lindner JL; Lin X; Liu YL; Silverman JF
    Diagn Cytopathol; 2006 Dec; 34(12):801-6. PubMed ID: 17115439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cytomorphologic concomitant reactions in malignant pleural effusions].
    Greis M; Atay Z
    Pneumologie; 1990 Feb; 44 Suppl 1():263-4. PubMed ID: 1694998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Malignant pleural effusions.
    Sahn SA
    Clin Chest Med; 1985 Mar; 6(1):113-25. PubMed ID: 2988851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
    Ylagan LR; Zhai J
    Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prospective comparison of the diagnostic value of cytology and immunocytology in pleural effusion studied by thoracoscopy and biopsy].
    Neubauer A; Thalmann U; Musch R; Grosser H; Loddenkemper R; Huhn D
    Klin Wochenschr; 1987 May; 65(9):400-6. PubMed ID: 3298829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence-based guidelines to optimize the selection of antibody panels in cytopathology: pleural effusions with malignant epithelioid cells.
    Westfall DE; Fan X; Marchevsky AM
    Diagn Cytopathol; 2010 Jan; 38(1):9-14. PubMed ID: 19626629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical value of CYFRA21-1, NSE, CA15-3, CA19-9 and CA125 assay in the elderly patients with pleural effusions.
    Li CS; Cheng BC; Ge W; Gao JF
    Int J Clin Pract; 2007 Mar; 61(3):444-8. PubMed ID: 17313612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [In vitro induction of mature dendritic cells from malignant pleural effusions].
    Huang H; Zeng BH; Chen JQ
    Ai Zheng; 2005 Jun; 24(6):663-6. PubMed ID: 15946474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psammoma bodies in small cell carcinoma of the lung: a case report.
    Bauer TW; Erozan YS
    Acta Cytol; 1982; 26(3):327-30. PubMed ID: 6285655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytomorphology and marker expression of malignant neuroendocrine cells in pleural effusions.
    Banner BF; Warren WH; Gould VE
    Acta Cytol; 1986; 30(2):99-104. PubMed ID: 3008474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effusion cytology in the diagnosis of malignant epithelioid and biphasic pleural mesothelioma.
    Sherman ME; Mark EJ
    Arch Pathol Lab Med; 1990 Aug; 114(8):845-51. PubMed ID: 2375659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effusion cytology of desmoplastic small round cell tumor of the pleura. A case report.
    Bian Y; Jordan AG; Rupp M; Cohn H; McLaughlin CJ; Miettinen M
    Acta Cytol; 1993; 37(1):77-82. PubMed ID: 7679537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of immunophenotype of lymphoid cells isolated from malignant pleural effusions.
    Jezewska E; Sikora J; Słowik-Gabryelska A; Zeromski J
    Arch Immunol Ther Exp (Warsz); 1993; 41(1):51-6. PubMed ID: 8239908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Presence of serum anti-p53 antibodies is associated with pleural effusion and poor prognosis in lung cancer patients.
    Lai CL; Tsai CM; Tsai TT; Kuo BI; Chang KT; Fu HT; Perng RP; Chen JY
    Clin Cancer Res; 1998 Dec; 4(12):3025-30. PubMed ID: 9865916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Results of combined blind pleural biopsy and cytology in the differential diagnosis of pleural effusions].
    Barthel E; Krecklow B
    Z Erkr Atmungsorgane; 1984; 163(1):61-4. PubMed ID: 6485395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Can carcinoma cells in ascitic and pleural effusions be reliably identified by immunocytochemical detection of "panepithelial antigens" EMA, egp34, BW-495 and TAG-72?].
    Mezger J; Stötzer O; Schilli G; Bauer S; Wilmanns W
    Pathologe; 1991 Jan; 12(1):30-4. PubMed ID: 2023891
    [No Abstract]   [Full Text] [Related]  

  • 40. [Lymphocyte and lymphocyte subsets in pleural fluid--comparison of malignant and non-malignant disorders].
    Klimiuk J; Domagała-Kulawik J; Krenke R; Chazan R
    Pol Arch Med Wewn; 2004 Mar; 111(3):291-6. PubMed ID: 15230209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.